Meningococcal Vaccine (Group A, C, Y & W-135)
Information about Meningococcal Vaccine (Group A, C, Y & W-135)
Meningococcal Vaccine (Group A, C, Y & W-135) Uses
Meningococcal Vaccine (Group A, C, Y & W-135) is used to prevent meningococcal disease.
How Meningococcal Vaccine (Group A, C, Y & W-135) works
Meningococcal Vaccine (Group A, C, Y & W-135) is a vaccine which helps develop immunity by initiating a mild infection. This type of infection does not cause illness but stimulates the body's immune system to produce antibodies (proteins) to protect against any future infections.
Common side effects of Meningococcal Vaccine (Group A, C, Y & W-135)
Headache, Injection site pain, Injection site redness, Injection site induration (hardening of a normally soft tissue or organ), Irritability, Sleepiness, General discomfort, Muscle pain, Nausea
Available Medicine for Meningococcal Vaccine (Group A, C, Y & W-135)
Mencevax AcwyGlaxo SmithKline Pharmaceuticals Ltd
₹10502 variant(s)
QuadrimeningoBio-Med Pvt Ltd
₹6501 variant(s)
MenveoGlaxoSmithKline Consumer Healthcare
₹42991 variant(s)
Quadri MeningoBiomed Pharmaceuticals
₹11501 variant(s)
Expert advice for Meningococcal Vaccine (Group A, C, Y & W-135)
- Meningococcal Vaccine (Group A, C, Y & W-135) is used to prevent meningococcal disease.
- It is not recommended for use in infants and children under 9 months of age.
- It is usually given by injection into the muscle of the upper arm.
- Your doctor will advise you if and when you should receive a booster dose.
- Immunocompromised individuals or persons suffering from functional or anatomic asplenia (including sickle cell disease) should get it.
- People travelling to US & Europe, Hajj (as meningococcal meningitis is more prevalent there) are advised to get vaccinated with Meningococcal Vaccine (Group A, C, Y & W-135).